Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: Associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition

被引:42
作者
Barber, Thomas M. [1 ]
Hazell, Matthew [2 ]
Christodoulides, Constantinos
Golding, Stephen J. [3 ]
Alvey, Christopher [3 ]
Burling, Keith [4 ]
Vidal-Puig, Antonio [4 ]
Groome, Nigel P. [2 ]
Wass, John A. H.
Franks, Stephen [5 ]
McCarthy, Mark I.
机构
[1] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Diabet Res Labs, Oxford OX3 7LJ, England
[2] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England
[3] John Radcliffe Hosp, Dept Radiol, Oxford OX3 9DU, England
[4] Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0QQ, England
[5] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England
基金
英国医学研究理事会;
关键词
D O I
10.1210/jc.2007-2759
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Insulin resistance, which associates with levels of retinol-binding protein 4 (RBP4) and adiponectin, is implicated in the development of polycystic ovary syndrome ( PCOS). Objective: The objective of the study was to explore the potential contribution of RBP4 and adiponectin in the etiology of PCOS and their relationships with specific fat depot measurements. Design: This was a cross-sectional study. Setting and Participants: Serum RBP4 and adiponectin levels were compared between 50 PCOS cases and 28 female controls (including 22 body mass index/fat mass-matched pairs) and correlated with specific fat depot ( including visceral) axial magnetic resonance imaging cross-sectional area measurements. All subjects were of U. K. British/ Irish origin. Main Outcome Measure(s): Serum levels of RBP4 ( automated immunonephelometric assay) and adiponectin [immunoassay: total and high molecular weight (HMW)]. Data are reported as geometric mean (SD, range) and optionally adjusted for fat mass and age. Results: Between the 50 PCOS cases and 28 controls, serum RBP4 levels were indistinguishable [39.0 mu g/ml (31.0, 49.0) vs. 41.6 mu g/ml (32.7, 52.9), respectively, unadjusted P = 0.24; adjusted P = 0.55]. Total ( and HMW) adiponectin levels were lower in PCOS cases [ total adiponectin 19.9 mu g/ml (14.2, 27.8) vs. 25.8 mu g/ml (17.7, 37.7), respectively, unadjusted P = 2.4 x 10(-3); adjusted P = 0.10]. For the paired-sample analyzes, there were no differences in RBP4 (P = 0.09), total adiponectin ( P = 0.06), HMW adiponectin ( P = 0.19), or HMW to total adiponectin ratio (P = 0.98). In PCOS cases, L4-visceral fat area was associated positively with RBP4 ( r(2) = 0.34, P = 0.01) and negatively with HMW to total adiponectin ratio (r(2) = -0.44, P = 1.3 x 10(-3)). Controls showed similar relationships. Conclusions: Although associated with visceral fat, serum RBP4 and adiponectin levels do not play important, fat-mass-independent primary roles in the development of PCOS.
引用
收藏
页码:2859 / 2865
页数:7
相关论文
共 42 条
  • [1] PREVALENCE OF POLYCYSTIC OVARIES IN WOMEN WITH ANOVULATION AND IDIOPATHIC HIRSUTISM
    ADAMS, J
    POLSON, DW
    FRANKS, S
    [J]. BRITISH MEDICAL JOURNAL, 1986, 293 (6543) : 355 - 359
  • [2] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
    Arita, Y
    Kihara, S
    Ouchi, N
    Takahashi, M
    Maeda, K
    Miyagawa, J
    Hotta, K
    Shimomura, I
    Nakamura, T
    Miyaoka, K
    Kuriyama, H
    Nishida, M
    Yamashita, S
    Okubo, K
    Matsubara, K
    Muraguchi, M
    Ohmoto, Y
    Funahashi, T
    Matsuzawa, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 79 - 83
  • [3] Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: Association with subclinical inflammation
    Balagopal, Prabhakaran
    Graham, Timothy E.
    Kahn, Barbara B.
    Altomare, Astride
    Funanage, Vicky
    George, Donald
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (05) : 1971 - 1974
  • [4] Obesity and polycystic ovary syndrome
    Barber, T. M.
    McCarthy, M. I.
    Wass, J. A. H.
    Franks, S.
    [J]. CLINICAL ENDOCRINOLOGY, 2006, 65 (02) : 137 - 145
  • [5] Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome
    Barber, Thomas M.
    Wass, John A. H.
    McCarthy, Mark I.
    Franks, Stephen
    [J]. CLINICAL ENDOCRINOLOGY, 2007, 66 (04) : 513 - 517
  • [6] The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome
    Bik, Wojciech
    Baranowska-Bik, Agnieszka
    Wolinska-Witort, Ewa
    Chmielowska, Magdalena
    Martynska, Lidia
    Baranowska, Boguslawa
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (06) : 325 - 331
  • [7] Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
    Dunaif, A
    [J]. ENDOCRINE REVIEWS, 1997, 18 (06) : 774 - 800
  • [8] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
    Fauser, BCJM
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. HUMAN REPRODUCTION, 2004, 19 (01) : 41 - 47
  • [9] Follicular dynamics in the polycystic ovary syndrome
    Franks, S
    Mason, H
    Willis, D
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 163 (1-2) : 49 - 52
  • [10] Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome
    Glintborg, Dorte
    Frystyk, Jan
    Hojlund, Kurt
    Andersen, Kristian Kjaer
    Henriksen, Jan Erik
    Hermann, Anne Pernille
    Hagen, Claus
    Flyvbjerg, Allan
    Andersen, Marianne
    [J]. CLINICAL ENDOCRINOLOGY, 2008, 68 (02) : 165 - 174